ORCID as entered in ROS

Select Publications
2023, 'Potential of graphene-modified nanostructures for multifunctional personal protective clothing', in Smart Nanomaterials to Combat the Spread of Viral Infections, Academic Press, pp. 195 - 218, http://dx.doi.org/10.1016/B978-0-323-99148-3.00011-X
,2021, 'Towards understanding cybersecurity capability in Australian healthcare organisations: a systematic review of recent trends, threats and mitigation', in Health Security Intelligence, Routledge, pp. 92 - 121, http://dx.doi.org/10.4324/9781003245483-8
,2021, 'The adaptability and resilience of cities to major epidemics: A comparison of Sydney and Phoenix subject to a hypothetical smallpox epidemic', in Inoculating Cities: Case Studies of Urban Pandemic Preparedness, pp. 171 - 199, http://dx.doi.org/10.1016/B978-0-12-820204-3.00010-3
,2021, 'The adaptability and resilience of cities to major epidemics', in Inoculating Cities, Elsevier, pp. 171 - 199, http://dx.doi.org/10.1016/b978-0-12-820204-3.00010-3
,2017, 'Facemasks and Respirators for the Prevention of Infection in Healthcare and Community Settings', in Handbook of Respiratory Protection Safeguarding Against Current and Emerging Hazards, CRC Press, pp. 338 - 375
,2017, 'Facemasks and respirators for the prevention of infection in healthcare and community settings', in Handbook of Respiratory Protection: Safeguarding Against Current and Emerging Hazards, pp. 335 - 386
,2017, 'Facemasks and Respirators for the Prevention of Infection in Healthcare and Community Settings', in Handbook of Respiratory Protection, CRC Press, pp. 335 - 386, http://dx.doi.org/10.4324/9781351109079-16
,2011, 'Modeling in Immunization and Biosurveillance Research', in Castillo-Chavez C; Zeng D (ed.), Infectious Disease Informatics and Biosurveillance, Springer Science+Business Media, LLC, New York, pp. 259 - 278, http://dx.doi.org/10.1007/978-1-4419-6892-0_12
,2004, 'Using evidence to inform decisions', in Moyer VA; Elliot EJ (ed.), Evidence-based pediatrics and child health, BMJ Publishing Group, London, pp. 161 - 166
,2025, 'Agent-Based Models of Virus Infection', Current Clinical Microbiology Reports, 12, http://dx.doi.org/10.1007/s40588-024-00238-5
,2025, 'An infection risk model for estimating infection probability and occupancy time: A CFD approach with aerosol measurements', Building and Environment, 279, http://dx.doi.org/10.1016/j.buildenv.2025.113035
,2025, 'Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023', Health Expectations, 28, http://dx.doi.org/10.1111/hex.70273
,2025, 'Long COVID clinical evaluation, research and impact on society: a global expert consensus', Annals of Clinical Microbiology and Antimicrobials, 24, pp. 27, http://dx.doi.org/10.1186/s12941-025-00793-9
,2025, 'A comparison of fit, heat stress, oxygen saturation and comfort between a novel reusable mask and disposable N95 respirator', Plos One, 20, http://dx.doi.org/10.1371/journal.pone.0321538
,2025, 'Prevention of Cardiovascular Diseases with Standard-Dose Quadrivalent Influenza Vaccine in People Aged ≥50 Years in Australia During the 2017 A/H3N2 Epidemic', Vaccines, 13, http://dx.doi.org/10.3390/vaccines13040407
,2025, 'A Geospatial Perspective Toward the Role of Wild Bird Migrations and Global Poultry Trade in the Spread of Highly Pathogenic Avian Influenza H5N1', Geohealth, 9, http://dx.doi.org/10.1029/2024GH001296
,2025, 'The impact of the cruise ship Coral Princess on COVID-19 transmission in regional Western Australia in 2022', Journal of Travel Medicine, 32, http://dx.doi.org/10.1093/jtm/taae044
,2025, 'Thinking globally for pandemic early warning systems: Infectious diseases', Nature Medicine, 31, pp. 731 - 732, http://dx.doi.org/10.1038/s41591-024-03460-2
,2025, 'Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer', Vaccine, 46, http://dx.doi.org/10.1016/j.vaccine.2024.126547
,2025, 'Corrigendum to “Wearing time and respiratory volume affect the filtration efficiency of masks against aerosols at different sizes” [Environ. Technol. Innov. 25 (2022) 102165] (Environmental Technology & Innovation (2022) 25, (S2352186421007720), (10.1016/j.eti.2021.102165))', Environmental Technology and Innovation, 37, http://dx.doi.org/10.1016/j.eti.2025.104056
,2025, 'Global Epidemiology of Outbreaks of Unknown Cause Identified by Open-Source Intelligence, 2020–2022', Emerging Infectious Diseases, 31, pp. 298 - 308, http://dx.doi.org/10.3201/eid3102.240533
,2025, 'Biowarfare scare: Pakistani judges under threat from suspicious substance', Global Biosecurity, 7, http://dx.doi.org/10.31646/gbio.271
,2025, 'Deadly Mass Methanol Poisoning in Laos, 2024', Global Biosecurity, 7, http://dx.doi.org/10.31646/gbio.310
,2025, 'Corrigendum to “Influenza B/Yamagata - extinct, eradicated or hiding? [Vaccine 42/26 (2024) 126450]” (Vaccine (2025) 44, (S0264410X24011320), (10.1016/j.vaccine.2024.126450))', Vaccine, 44, http://dx.doi.org/10.1016/j.vaccine.2024.126486
,2025, 'Influenza B/Yamagata cannot currently be declared extinct', Vaccine, 44, http://dx.doi.org/10.1016/j.vaccine.2024.126450
,2025, 'Overall cardioprotective effects of COVID mRNA vaccines', European Heart Journal, 46, pp. 158 - 160, http://dx.doi.org/10.1093/eurheartj/ehae800
,2025, 'Application of the Modified Grunow-Finke Risk Assessment Tool to the Sverdlovsk Anthrax Outbreak of 1979', Military Medicine, 190, pp. e59 - e66, http://dx.doi.org/10.1093/milmed/usae289
,2025, 'Mapping biosafety level 3 (BSL-3) and BSL-4 laboratories for public health threats reduction', Journal of Public Health (Germany), http://dx.doi.org/10.1007/s10389-025-02492-3
,2025, 'The role of masks and respirators in preventing respiratory infections in healthcare and community settings', BMJ, http://dx.doi.org/10.1136/bmj-2023-078573
,2025, 'Analysing Open-source Images to Assess Face Mask Usage for Epidemiological Studies', International Journal of Infectious Diseases, 152, pp. 107407 - 107407, http://dx.doi.org/10.1016/j.ijid.2024.107407
,2025, 'Enhanced surveillance of a pneumonia outbreak of unknown cause in Argentina in 2022 using the AI system, EPIWATCH', International Journal of Infectious Diseases, 152, pp. 107571 - 107571, http://dx.doi.org/10.1016/j.ijid.2024.107571
,2025, 'EPIWATCH, an artificial intelligence early-warning system as a valuable tool in outbreak surveillance', International Journal of Infectious Diseases, 152, pp. 107579 - 107579, http://dx.doi.org/10.1016/j.ijid.2024.107579
,2024, 'Acute hepatitis of unknown aetiology in children: evidence for and against causal relationships with SARS-CoV-2, HAdv and AAV2', BMJ Paediatrics Open, 8, http://dx.doi.org/10.1136/bmjpo-2023-002410
,2024, 'Impact of vaccine coverage and disruption to health services on COVID-19 in Ukraine', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-57447-7
,2024, 'Predicting vaccine effectiveness for mpox', Nature Communications, 15, pp. 3856, http://dx.doi.org/10.1038/s41467-024-48180-w
,2024, 'Origin of the H1N1 (Russian influenza) pandemic of 1977—A risk assessment using the modified Grunow–Finke tool (mGFT)', Risk Analysis, 44, pp. 2696 - 2706, http://dx.doi.org/10.1111/risa.14343
,2024, 'The risk of cognitive decline and dementia in older adults diagnosed with COVID-19: A systematic review and meta-analysis', Ageing Research Reviews, 101, http://dx.doi.org/10.1016/j.arr.2024.102448
,2024, 'Attitudes and Behaviours Regarding COVID-19 Mitigation Strategies in Australians With an Underlying Health Condition: A Cross-Sectional Study', Health Expectations, 27, pp. e70025, http://dx.doi.org/10.1111/hex.70025
,2024, 'Experimental framework to examine turbulent puffs generated by human coughing', Physics of Fluids, 36, http://dx.doi.org/10.1063/5.0225782
,2024, 'Using EPIWATCH® open-source surveillance to describe the epidemiology of lumpy skin disease outbreaks in South and Southeast Asia (2022–2023)', Australian Veterinary Journal, 102, pp. 524 - 529, http://dx.doi.org/10.1111/avj.13362
,2024, 'Coverage of influenza, pneumococcal and zoster vaccination and determinants of influenza and pneumococcal vaccination among adults with cardiovascular diseases in community', Vaccine, 42, http://dx.doi.org/10.1016/j.vaccine.2024.05.051
,2024, 'A numerical framework for the analysis of indoor air quality in a classroom', Journal of Building Engineering, 92, pp. 109659, http://dx.doi.org/10.1016/j.jobe.2024.109659
,2024, 'Use of Open-Source Epidemic Intelligence for Infectious Disease Outbreaks, Ukraine, 2022', Emerging Infectious Diseases, 30, pp. 1865 - 1871, http://dx.doi.org/10.3201/eid3009.240082
,2024, 'The public health and economic burden of long COVID in Australia, 2022–24: a modelling study', Medical Journal of Australia, 221, pp. 217 - 223, http://dx.doi.org/10.5694/mja2.52400
,2024, 'Use of a risk assessment tool to determine the origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)', Risk Analysis, 44, pp. 1896 - 1906, http://dx.doi.org/10.1111/risa.14291
,2024, 'Leveraging Simulation Data to Understand Bias in Predictive Models of Infectious Disease Spread', ACM Transactions on Spatial Algorithms and Systems, 10, http://dx.doi.org/10.1145/3660631
,2024, 'Prevalence of influenza and other acute respiratory illnesses in patients with acute myocardial infarction in Bangladesh: A cross-sectional study', Health Science Reports, 7, http://dx.doi.org/10.1002/hsr2.2234
,2024, 'Reducing airborne transmissible diseases in perioperative environments', British Journal of Anaesthesia, 133, pp. 19 - 23, http://dx.doi.org/10.1016/j.bja.2024.03.025
,2024, 'Masks and respirators for prevention of respiratory infections: a state of the science review', Clinical Microbiology Reviews, 37, pp. e00124 - e00123, http://dx.doi.org/10.1128/cmr.00124-23
,2024, 'Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases', Vaccine, 42, pp. 3404 - 3409, http://dx.doi.org/10.1016/j.vaccine.2024.04.031
,